TY - JOUR
T1 - Factors Associated with Eczema Clinical Trial Awareness, Interest, and Participation in Adults
AU - Grinich, Erin E.
AU - Thibau, Isabelle J.
AU - Latour, Emile
AU - Price, Kyla N.
AU - Loiselle, Allison R.
AU - Simpson, Eric
AU - Smith Begolka, Wendy
N1 - Publisher Copyright:
© 2023, Medical Journals/Acta D-V. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Despite the need for improved eczema therapies and a rapid increase in available eczema clinical trials, participation remains low. The aim of this study was to identify factors associated with clinical trial awarene-ss, interest, and barriers to enrolment and participation. An online survey, administered 1 May to 6 June 2020 to adults (≥ 18 years) with eczema in the USA, was analysed. Among 800 patients included, mean age was 49.4 years, most respondents were female (78.1%), White (75.4%), non-Hispanic (91.4%), and geographically living in an urban/suburban area (Rural-Urban Continuum Codes (RUCC) 1–3, 90.8%). Only 9.7% of respondents reported previous participation in clinical trials, while 57.1% had considered participation and 33.2% never considered participation. Higher satisfaction with current eczema therapy, clinical trial literacy, and confidence in finding eczema trial information were all associated with clinical trial awa-reness, interest, and successful participation. Younger age and having atopic dermatitis were associated with increased awareness, while female gender was a bar-rier to interest and successful participation.
AB - Despite the need for improved eczema therapies and a rapid increase in available eczema clinical trials, participation remains low. The aim of this study was to identify factors associated with clinical trial awarene-ss, interest, and barriers to enrolment and participation. An online survey, administered 1 May to 6 June 2020 to adults (≥ 18 years) with eczema in the USA, was analysed. Among 800 patients included, mean age was 49.4 years, most respondents were female (78.1%), White (75.4%), non-Hispanic (91.4%), and geographically living in an urban/suburban area (Rural-Urban Continuum Codes (RUCC) 1–3, 90.8%). Only 9.7% of respondents reported previous participation in clinical trials, while 57.1% had considered participation and 33.2% never considered participation. Higher satisfaction with current eczema therapy, clinical trial literacy, and confidence in finding eczema trial information were all associated with clinical trial awa-reness, interest, and successful participation. Younger age and having atopic dermatitis were associated with increased awareness, while female gender was a bar-rier to interest and successful participation.
KW - atopic dermatitis
KW - biomedical translational science
KW - clinical trials
KW - eczema
KW - health literacy
KW - patient recruitment
UR - http://www.scopus.com/inward/record.url?scp=85162716769&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85162716769&partnerID=8YFLogxK
U2 - 10.2340/actadv.v103.6520
DO - 10.2340/actadv.v103.6520
M3 - Article
C2 - 37338147
AN - SCOPUS:85162716769
SN - 0001-5555
VL - 103
JO - Acta dermato-venereologica
JF - Acta dermato-venereologica
M1 - adv006520
ER -